Skip to main content
. 2021 Jan 27;10:592884. doi: 10.3389/fonc.2020.592884

Figure 4.

Figure 4

circ_0014717 sponged miR-668-3p in hepatocellular carcinoma (HCC) cells. (A, B) Top six miRNA candidates in HCC cell lysates were tested by real-time PCR. Multiple miRNAs were pulled down using circ_0014717 probe. (C) The expression level of miR-668-3p in HCC cells infected with LV-circ_0014717 or LV-NC. (D) The putative binding sites between circ_0014717 and miR-668-3p. (E, F) Luciferase activity was evaluated in HCC cells co-transfected with circ_0014717-WT or circ_0014717-MUT reporter and miR-668-3p inhibitors or its scramble control (NC). (G) The expression of miR-668-3p in HCC carcinoma and normal adjacent tissues. (H) The expression of miR-668-3p in HCC cells (Huh-7, Hep-3B, HepG2, SMMCC-7721, MHCC97L) and LO2 cells. *P < 0.05.